The CDC revised its pneumococcal pneumonia shot recommendation, saying there is a substantial increase in the risk for infection beginning at age 50.

Dr. Matthew Simmons, UPMC Western Maryland vice president of medical staff affairs, said vaccines provide the "single most powerful intervention" that have saved lives. He recently discussed the ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results ... although – following the Capvaxive approval – the CDC's Advisory Committee on Immunisation Practices (ACIP) is ...

Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.

The Centers for Disease Control and Prevention (CDC) is scheduled to review ... Prior to COVID-19, pneumococcal vaccines were the largest vaccine market worldwide – estimated at around $8 ...

The CDC’s Advisory Committee on Immunization ... and that age-targeted approach is central to MSD’s targeted pneumococcal vaccine strategy. It is also deploying its age-targeted serotype ...

Pfizer’s latest-generation pneumococcal conjugate vaccine is in line to reach more ... and recently scored a key endorsement from the CDC’s Advisory Committee on Immunization Practices ...

While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults. The most common symptoms include cough, chills and fever.

After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.”  | The company benefited from higher-than-expected sales of ...

The Advisory Committee on Immunization Practices — an influential group of clinicians and scientists — recommends who should get vaccines to the Centers for Disease Control and Prevention, the ...

The Advisory Committee on Immunization Practices approved immunization schedules for children and adolescents and for adults for 2025.